Walter A Wohlgemuth1, Rene Müller-Wille2, Veronika Teusch2, Simone Hammer2, Moritz Wildgruber3, Wibke Uller2. 1. Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. walter.wohlgemuth@ukr.de. 2. Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. 3. Institut für klinische Radiologie, Universitätsklinikum Münster, Westfälische Wilhelms Universität, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Abstract
OBJECTIVES: To assess the treatment-induced changes of health-related quality-of-life (HRQoL) in patients with venous malformations (VM) who underwent ethanol gel sclerotherapy. METHODS: The prospective study in children and adults was approved by the local ethics committee. 31 patients (mean age 23.42 years, range 6.6 - 46.5; 26 female, 5 male) with VM were included. Patients' self-assessed HRQoL was measured before and after treatment using psychometrically validated questionnaires for adults and children. Differences were analysed with a paired t test. RESULTS: 58 sclerotherapy sessions were performed. The Physical Component Summary (PCS) at baseline was 43.69 and increased significantly (p = 0.01122) to 48.95 after treatment. The bodily pain (BP) scale increased significantly from 37.94 to 48.56 (p = 0.00002), the general health (GH) scale increased significantly from 46.69 to 52.17 (p = 0.00609). Baseline Physical Summary Score (PHS) in children increased significantly after treatment (p < 0.00001) from 25.25 to 45.89. The baseline Psychosocial Summary Score (PSS) in children was 51.08 and increased significantly (p = 0.00031) after treatment to 58.84. CONCLUSION: Paediatric and adult patients with VM suffer from bodily pain with overall reduced physical functioning. After sclerotherapy, these restrictions are successfully returning to normal levels with a positive effect on mental and psychosocial domains. KEY POINTS: • Sclerotherapy in venous malformation patients has an unknown effect on health-related quality-of-life • Prospective study showed improvements in bodily pain and general health in adults • Children and adults improved from treatment with ethanol gel • Sclerotherapy is an appropriate therapy.
OBJECTIVES: To assess the treatment-induced changes of health-related quality-of-life (HRQoL) in patients with venous malformations (VM) who underwent ethanol gel sclerotherapy. METHODS: The prospective study in children and adults was approved by the local ethics committee. 31 patients (mean age 23.42 years, range 6.6 - 46.5; 26 female, 5 male) with VM were included. Patients' self-assessed HRQoL was measured before and after treatment using psychometrically validated questionnaires for adults and children. Differences were analysed with a paired t test. RESULTS: 58 sclerotherapy sessions were performed. The Physical Component Summary (PCS) at baseline was 43.69 and increased significantly (p = 0.01122) to 48.95 after treatment. The bodily pain (BP) scale increased significantly from 37.94 to 48.56 (p = 0.00002), the general health (GH) scale increased significantly from 46.69 to 52.17 (p = 0.00609). Baseline Physical Summary Score (PHS) in children increased significantly after treatment (p < 0.00001) from 25.25 to 45.89. The baseline Psychosocial Summary Score (PSS) in children was 51.08 and increased significantly (p = 0.00031) after treatment to 58.84. CONCLUSION: Paediatric and adult patients with VM suffer from bodily pain with overall reduced physical functioning. After sclerotherapy, these restrictions are successfully returning to normal levels with a positive effect on mental and psychosocial domains. KEY POINTS: • Sclerotherapy in venous malformationpatients has an unknown effect on health-related quality-of-life • Prospective study showed improvements in bodily pain and general health in adults • Children and adults improved from treatment with ethanol gel • Sclerotherapy is an appropriate therapy.
Entities:
Keywords:
Adults; Children; Quality of life; Sclerotherapy; Vascular malformation
Authors: C Boetes; A P Boll; P H Hartman; C G van Oostrom; P N Rieu; M de Rooij; P H Spauwen; P M Steijlen Journal: Ned Tijdschr Geneeskd Date: 1997-03-29
Authors: B B Lee; I Baumgartner; P Berlien; G Bianchini; P Burrows; P Gloviczki; Y Huang; J Laredo; D A Loose; J Markovic; R Mattassi; K Parsi; E Rabe; M Rosenblatt; C Shortell; F Stillo; M Vaghi; L Villavicencio; P Zamboni Journal: Int Angiol Date: 2015-04 Impact factor: 2.789
Authors: Corstiaan C Breugem; Maruschka P Merkus; J Henk Sillevis Smitt; Dink A Legemate; Chantal M A M van der Horst Journal: Br J Plast Surg Date: 2004-12
Authors: Vanessa F Schmidt; Max Masthoff; Veronika Vielsmeier; Caroline T Seebauer; Özlem Cangir; Lutz Meyer; Antje Mükke; Werner Lang; Axel Schmid; Peter B Sporns; Richard Brill; Walter A Wohlgemuth; Natascha Platz Batista da Silva; Max Seidensticker; Regina Schinner; Julia Küppers; Beate Häberle; Frank Haubner; Jens Ricke; Martin Zenker; Melanie A Kimm; Moritz Wildgruber Journal: Cardiovasc Intervent Radiol Date: 2022-10-19 Impact factor: 2.797
Authors: Maliha Sadick; Walter A Wohlgemuth; Roland Huelse; Bettina Lange; Thomas Henzler; Stefan O Schoenberg; Haneen Sadick Journal: Eur J Radiol Open Date: 2017-05-14
Authors: Elizabeth Kenyon; Jennifer J Westerhuis; Maximilian Volk; Jeremy Hix; Shatadru Chakravarty; Ethan Claucherty; Erin Zaluzec; Lisa Ramsey; Zach Madaj; Galen Hostetter; Bryn Eagleson; Erik Shapiro; Anna Moore; Lorenzo F Sempere Journal: Breast Cancer Res Date: 2019-11-28 Impact factor: 6.466
Authors: Mirjam Gerwing; Philipp Schindler; Kristian Nikolaus Schneider; Benedikt Sundermann; Michael Köhler; Anna-Christina Stamm; Vanessa Franziska Schmidt; Sybille Perkowski; Niklas Deventer; Walter L Heindel; Moritz Wildgruber; Max Masthoff Journal: Diagnostics (Basel) Date: 2022-06-09
Authors: Sophie E R Horbach; Amber P M Rongen; Roy G Elbers; Chantal M A M van der Horst; Cecilia A C Prinsen; Phyllis I Spuls Journal: Qual Life Res Date: 2019-09-23 Impact factor: 4.147
Authors: Richard Brill; Moritz Wildgruber; Vanessa F Schmidt; Max Masthoff; Constantin Goldann; Sinan Deniz; Osman Öcal; Beate Häberle; Michael Köhler; Max Seidensticker; Jens Ricke; Walter A Wohlgemuth Journal: Cardiovasc Intervent Radiol Date: 2021-07-20 Impact factor: 2.740